CÉLULAS MADRE Y TERAPIA CELULAR
University of Manchester
Mánchester, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Manchester (6)
2015
-
Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1
American Journal of Medical Genetics, Part A, Vol. 167, Núm. 2, pp. 296-312
2013
-
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: A case-control study
The Lancet Neurology, Vol. 12, Núm. 12, pp. 1159-1169
-
LRIG2 mutations cause urofacial syndrome
American Journal of Human Genetics, Vol. 92, Núm. 2, pp. 259-264
-
Synonymous mutations in RNASEH2A create cryptic splice sites impairing RNase H2 enzyme function in aicardi-Goutières syndrome
Human Mutation, Vol. 34, Núm. 8, pp. 1066-1070
2010
-
Mutations in HPSE2 Cause Urofacial Syndrome
American Journal of Human Genetics, Vol. 86, Núm. 6, pp. 963-969
2009
-
Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response
Nature Genetics, Vol. 41, Núm. 7, pp. 829-832